Introduction
The class II MHC expressed by B cells, macrophages, dendritic cells and thymic epithelial cells is a heterodimeric molecule consisting of α and β chains. These two chains, the α and β, are involved in binding peptides by virtue of highly polymorphic residues found at the N-terminal domains which line the peptide-binding groove of the MHC molecules (1) . The class II MHC functions by binding self-peptides in the peptide-binding groove and by guiding the selection of CD4 ϩ lymphocytes in the thymus. It is also involved in presenting peptide antigens to CD4 ϩ cells in order to initiate immune responses.
After synthesis, the class II MHC molecule associates with the invariant chain (Ii) that serves to prevent premature the absence of H-2M, CLIP would prevent the binding of antigens in the binding groove and their subsequent presentation on the cell surface (7) . We have previously shown that saturating the endosomal compartment with exogenous CLIP down-regulates the surface MHC class II expression and inhibits the ability of antigenic epitopes to bind to class II MHC (15) .
The present study was undertaken to analyze the effect of exogenously added CLIP on the activation of T cells and on the T h cell subsets generated. Using confocal microscopy we show that CLIP is rapidly internalized by the antigenpresenting cells (APC) and it localizes into the subcellular compartment where class II MHC molecules are present. Exogenous CLIP may have a significant effect on the density of peptides being presented at the surface of the APC leading to modulation of T cell response. We hypothesized that since CLIP down-regulates MHC expression (15) , the density of peptide-MHC complexes at the surface may be altered such that a T h 2 rather than a T h 1 response may be induced to the peptides. Ovalbumin [(OVA)(323-339)] peptide and three I-A d -restricted peptides EYK(EYA) 3 , EYK(EYA) 4 and EYKE-YAAYA(EYA) 2 known as K3, K4 and K1A2 respectively with different affinities for class II MHC (I-A d ) (8) were used in the present study. We and others have shown that the CD4 T h 1 and T h 2 responses are induced depending on the affinity of the peptide antigen for MHC (8, 9) . The peptides K3, K4 and K1A2 induce responses of different magnitudes and generate T h 1-or T h 2-like cells depending on their affinity for I-A d (8) . Our results suggest that exogenously added CLIP is internalized and competes with peptide epitopes for binding to class II MHC molecules. This results in the down-regulation of antigen-specific responses. Analysis of cytokine secretion and antibody production indicates that it also causes the immune response to shift from a T h 1-like response towards a T h 2 response. T h 1 cells secrete IL-2 and IFN-γ (10), are responsible for mediating delayed-type hypersensitivity reaction (11) , and are involved in induction of IgG2a antibodies. T h 2 cells secrete IL-4, IL-5, IL-6 and IL-10 (10), and are involved in inducing humoral immune responses particularly IgE and IgG1 antibodies (12, 13) . T h 1 cells are often associated with certain autoimmune disorders and the ability of CLIP to shift the antigen-specific responses from pathogenic T h 1 to protective T h 2 may have implications in the treatment of such disorders.
Methods

Mice
BALB/c female mice (8-10 weeks old) used in this study were purchased from Jackson (Bar Harbor, ME).
Antigen
CLIP(85-101), FITC-CLIP(85-101), OVA(323-339), K1A2, K3 and K4 peptides were prepared by the Merrifield solidphase technique on a ABI 431A Peptide Synthesizer (Applied Biosytems, Mississauga, Ontario, Canada) as described earlier (14, 15) . The peptides were purified by HPLC on a C 18 reverse-phase semi-preparative SynChropak RP-P column (Synchrom, Linden, IN), using a linear gradient from water to acetonitrile (1.37% acetronitrile/min). For functional assays, peptides were dissolved in saline by adjusting pH to 7.2 with 0.1 N NaOH and were sterilized by filtration through a 0.22 µm filter. Abbreviations used for amino acids: K, lysine; E, glutamic acid; Y, tyrosine; A, alanine. Purified protein derivative (PPD; Statens Seruminstitut Tuberculin Department, Copenhagen, Denmark) was used at a concentration of 40 µg/ml as a positive control in adjuvant [complete Freund's adjuvant (CFA)]-primed mice.
Antibody
Anti-I-A d mAb MKD.6 (15) and TRITC-goat anti-mouse-FC (Sigma, St Louis, MO) were used in confocal microscopy.
Immunization and T cell proliferation assay BALB/c mice were immunized with 50 µg of K3, K4 or K1A2 emulsified in CFA (Sigma) in both the hind footpads. One group of mice was immunized with either of the peptides in the presence or absence of 50 µg CLIP or OVA(323-339) peptide. One group of mice was immunized with 50 µg of OVA protein (Sigma) along with 50 µg CLIP, or a control peptide K1A2. After 10 days, popliteal lymph nodes were removed and a single-cell suspension was prepared. The cells were then cultured in 96-well flatbottom plates (Becton Dickinson, Mississauga, ON) at 2ϫ10 5 cells/well in the presence or absence of the peptide (50 µg/ ml) in 200 µl of culture medium [RPMI 1640 (Gibco, Grand Island, NY) supplemented with 10% FCS (Bockneck, Rexdale, Ontario, Canada), 10 mM HEPES, 2 mM L-glutamine, 5ϫ10 -5 M 2-mercaptoethanol and 1 U/ml penicillin/streptomycin]. After 3 days, cultures were pulsed with 1 µCi/well of [ 3 H]thymidine (NEN Du Pont, Boston, MA) for 16-20 h. Incorporation of [ 3 H]thymidine was measured using a liquid scintillation counter (LKB, Gaithersburg, MD). Data is presented for one antigen concentration; however, results were obtained with various concentrations of the peptides or CLIP as we previously reported (8, 15) .
Cytokine assays
Cells (2ϫ10 6 ) from immunized mice were cultured in 24-well flat-bottom plates (Corning Glass Works, Corning, NY) in 2 ml medium in the presence or absence of the peptides K3, K4, K1A2 or OVA (50 µg/ml). Supernatants were collected at different time periods and assayed for different cytokine contents. IL-4 was assayed using IL-4-dependent CT4.S cells (kindly supplied by Dr B. Chan, Robarts Research Institute, London, Ontario, Canada). CT4.S cells were cultured with supernatant for 30 h. [ 3 H]Thymidine (1 µCi/well) was added and cultured for an additional 18 h. Incorporation of [ 3 H]thymidine was assayed as described above. A standard curve was obtained using IL-4-containing supernatant (starting at the highest concentration of 100 U/ml) from murine rIL-4 cDNA-transfected X63Ag8-653 myeloma cells (8) . Supernatants were also assayed for IFN-γ using cytokine-specific ELISA (PharMingen, Mississauga, Ontario, Canada). A standard curve was obtained using recombinant IFN-γ (starting at highest concentration of 40 ng/ml).
Antibody response
Mice were immunized with 50 µg K3, K4 or K1A2 in 50 µl saline emulsified in 50 µl of CFA in one hind footpad. One group of mice was injected with peptide plus CLIP (50 µg each) emulsified in CFA. After 2 weeks, a second injection of the respective peptide (50 µg) or peptide plus CLIP (50 µg each) emulsified in incomplete Freund's adjuvant (IFA) was given i.p. Blood was collected at different time intervals after the second injection and serum was separated. ELISA plates (Becton Dickinson) were coated with the peptide, and the isotype of antibodies generated against K3, K4 and K1A2 was detected by using goat anti-mouse IgG1 or IgG2a antibody (Caltag, San Francisco, CA).
Confocal microscopy
To determine uptake and localization of CLIP(85-101), a B cell hybridoma, TA3 cells, were incubated for various times with FITC-CLIP (100 µg/ml) at 37°C. Subsequently, cells were washed twice in PBS and incubated at room temperature on poly-L-lysine-coated glass coverslips (Sigma) for 15 min. Attached cells were fixed in 2% paraformaldehyde for 10 min at room temperature and washed in PBS. Cells were directly mounted on glass slides using Vectashield (Vector, Burlingame, CA) and visualized for fluorescence. For co-localization experiment, cells were attached to the glass coverslips and fixed in 2% paraformaldehyde. These cells 
Results
Exogenously added CLIP down-regulates the proliferative response to OVA protein
As protein antigens require processing before they are able to bind to MHC we examined if immunization with CLIP would modify the immune response to protein antigen in vivo. Mice were immunized with OVA protein (50 µg/hind footpad) with or without CLIP (50 µg/hind footpad) emulsified in CFA in both the hind footpads. After 10 days, lymph nodes were harvested and T cell proliferation was assayed. The results presented in Fig. 1 show that addition of CLIP during immunization down-regulated the proliferative response of mice to OVA protein. Possibly, exogenously added CLIP interferes with the binding of intracellularly processed peptide fragments of OVA to MHC molecules, decreasing the presentation to T cells, thus resulting in down-regulation of the proliferative response. Next we examined the effect of immunization with CLIP on the generation of T h 1 and T h 2 responses to OVA. The results presented in Fig. 2 show a higher level of IL-4 secretion upon immunization with OVA plus CLIP and a decreased level of IFN-γ suggesting a shift from a T h 1-to T h 2-type response. On the other hand, the control peptide K1A2 used in place of CLIP did not have any 
Exogenously added CLIP inhibits the in vivo response to peptides
We have previously reported that exogenous CLIP binds poorly to cell surface MHC class II molecules (15) but it down-regulates the surface expression of class II molecules. To determine the effect of CLIP on the presentation of peptide antigens by APC, BALB/c mice were immunized with CLIP or a control OVA(323-339) peptide (50 µg/footpad) along with three related homologous peptide antigens K3, K4 or K1A2 (50 µg/footpad). Peptide K3 has low affinity and K1A2 has high affinity, while K4 has an intermediate affinity for I-A d molecules (8) . Ten days later, lymph nodes were harvested and T cell proliferation was assayed. Immunization with the peptides in the presence of CLIP down-regulated the proliferative response compared to immunization with peptides alone (Fig. 3) . However, the effect of CLIP was more pronounced when OVA protein was used. As expected, addition of the OVA(323-339) peptide that binds to I-A d in place of CLIP also resulted in a reduction in the response. This suggests that both CLIP and OVA(323-339) peptide compete with K3, K4 or K1A2 peptides for binding to MHC, resulting in inhibition of the presentation of the antigens to T cells and subsequent down-regulation of the immune response.
Exogenously added CLIP shifts the immune response toward T h 2
We have reported earlier that high-affinity peptide K1A2 induces the generation of a T h 1-type response while lowaffinity peptide K3 induces a T h 2-type response. The peptide Mice were immunized with OVA (50 µg/footpad) in the presence or absence of CLIP (50 µg/footpad). After 10 days, lymph nodes were collected and cells were cultured with OVA (50 µg/ml). Culture supernatants were collected after 24 h, and tested for the presence of IL-4 and IFN-γ as described in Methods. For IL-4 assay, CT4.S cells were cultured with supernatant for 30 h. [ 3 H]Thymidine (1 µCi/ well) was added and cultured for an additional 18 h. Incorporation of [ 3 H]thymidine was measured as described in Methods. A standard curve was obtained using IL-4 starting with a highest concentration of 100 U/ml. IFN-γ was assayed using cytokine-specific ELISA as described in Methods. A standard curve was obtained using recombinant IFN-γ starting with a highest concentration of 40 ng/ml. Statistically significant differences where * P Ͻ 0.02.
K4 with intermediate affinity induces both T h 1 and T h 2 responses (8).
To analyze whether down-regulation of antigen presentation by CLIP alters the differentiation of T h 1 and T h 2 cells in response to peptide antigens, mice were immunized with peptides in the presence of CLIP or OVA peptide. After 10 days, draining lymph nodes were harvested and cells were cultured in the presence of peptides. Supernatants were collected and assayed for the presence of IL-4 and IFN-γ. The data presented in Fig. 4 shows that addition of exogenous CLIP resulted in decreased IFN-γ production by K4-and K1A2-primed cells. On the other hand, IL-4 production by K3 and K4 was up-regulated and a small amount of IL-4 was detected in K1A2-primed cell culture. Immunization with OVA peptide in place of CLIP resulted in increased IFN-γ production by K4-and K1A2-primed cells, and a small amount of IFN-γ was detected in K3-primed cell culture. This suggests that addition of exogenous CLIP to peptide antigens shifts the response towards the T h 2 type while OVA peptide up-regulates the already existing T h 1 response. Although addition of OVA(323-339) peptide during immunization down-regulated the IL-4 production in K3-primed cell cultures it did not have any effect on IL-4 production by K4-primed cells. Immunization with K3 in the presence of OVA(323-339) peptide did not up-regulate the IFN-γ production significantly. Therefore, the control OVA(323-339) peptide being immunogenic affects the outcome of the response but CLIP modulates the immune response to a greater extent (Fig. 4) .
Exogenously added CLIP shifts the isotype of peptide-specific antibodies from IgG2a to IgG1
Mice were immunized with K3, K4 or K1A2 peptides (50 µg/ footpad) with or without CLIP (50 µg/footpad) emulsified in CFA. Two weeks later mice were given a second injection of peptides (100 µg) emulsified in IFA with or without CLIP (100 µg). Mice were bled 2 weeks after the second injection, and the serum was then assayed for the presence of IgG1 and IgG2a antibodies. The peptide K3 induces very low levels of both IgG1 and IgG2a isotype antibodies. Addition of CLIP to the peptide increased the levels of IgG1 antibodies indicating an increase in the T h 2 response. On the other hand, immunization with K4 and CLIP did not seem to have an effect on IgG1 response but down-regulated the IgG2a response, suggesting down-regulation of the T h 1-type response while the T h 2 response is maintained. The third peptide, K1A2, displayed the biggest shift in antibody response upon addition of CLIP. The IgG1 antibody response increased when CLIP was added, whereas the IgG2a response was significantly reduced, suggesting a shift from a strong T h 1 to a T h 2 response (Fig. 5) . These results confirm the results obtained from cytokine studies. ]thymidine was measured as described in Methods. A standard curve was obtained using IL-4 starting at a highest concentration of 100 U/ml. IFN-γ was assayed using cytokinespecific ELISA as described in Methods. A standard curve was obtained using recombinant IFN-γ starting with a highest concentration of 40 ng/ml. For IL-4 assay, statistically significant differences where * P Ͻ 0.05, ** P ϭ 0.02 and *** P ϭ 0.05; for IFN-γ assay * P Ͻ 0.02 and ** P Ͻ 0.01.
CLIP co-localizes in an intracellular, MHC-containing endosomal compartment
In a previous study we have shown that CLIP down-regulates the cell surface expression of MHC class II molecules (15) . To determine how CLIP down-regulates the MHC expression, uptake of CLIP by TA3 cells and its localization inside the cell was examined using confocal microscopy. We postulated that exogenous CLIP was localizing in the MHC-containing compartments where peptide-loading takes place. Based on this assumption we performed co-localization experiments using permeabilized or unpermeabilized TA3 cells. Cells were incubated with FITC-CLIP, anti-I-A d antibody or both and visualized under a confocal microscope. The images Fig. 5 . Effect of immunization with CLIP on the peptide-specific antibody response. BALB/c mice were immunized with K3, K4 or K1A2 (50 µg/footpad) in CFA in the presence or absence of CLIP (50 µg/footpad) in one footpad. After 2 weeks, a second injection of the respective peptide in IFA was given i.p. Serum was collected after 2 weeks and the antibody isotypes (IgG2a and IgG1) generated were determined using ELISA as described in Methods. ELISA was performed using various dilutions (1:10-1:80) of sera. Normal control serum did not bind to the peptides in this assay (data not shown).
presented in Fig. 6 show that both CLIP and I-A d antibody bind to the cell surface of unpermeabilized cells. The binding of anti-I-A d antibody seems to be more intense compared to binding of CLIP that appeared rather diffused. Incubation of unpermeabilized TA3 cells with both FITC-CLIP and anti-I-A d did not show appreciable co-localization on the surface. However, when permeabilized cells were used, CLIP appears to localize in well-defined subcellular vesicular structures. The permeabilized cells stained for both I-A d and CLIP demonstrate that CLIP co-localized with I-A d (Fig. 6 ). This suggests that exogenously added CLIP is internalized and is localized in the MHC-containing subcellular vesicles. To further confirm that exogenous CLIP is internalized, TA3 cells were incubated with FITC-labeled CLIP for various times and visualized directly by confocal microscope (Fig. 7) . It was observed that CLIP binds to the surface initially and is internalized in a time-dependent fashion localizing in welldefined subcellular vesicles as observed in the co-localization experiment (Fig. 6 ). Over a 2 h time course exogenous CLIP is internalized through cell surface-associated subcellular vesicles and localizes with class II MHC as observed in Fig. 6 . 
Discussion
MHC molecules need a transport-competent conformation for effective post-endoplasmic reticulum transport. Class II MHC molecules assemble as a stoichiometric complex with trimers of the type II integral membrane glycoprotein Ii (16) . The interaction with the Ii chain: (i) contributes to efficient stable association of the class II α and β subunits in the endoplasmic reticulum (17, 18) , (ii) promotes the transport of class II α/β heterodimers from the endoplasmic reticulum through the Golgi complex (17, (19) (20) (21) (22) , and (iii) inhibits the binding of other ligands (peptides) to the class II molecules (6, 23, 24) . The α/β-Ii complex undergoes extensive modification during its transport through the Golgi to endosomes where the tail portion of the Ii is degraded. This leaves CLIP(85-101) in contact with the α/β heterodimer (3, 4) . CLIP has been shown to prevent peptide binding to the major groove of the MHC class II molecule (5, 6) . Therefore, for efficient peptide binding to MHC and subsequent presentation to T cells, CLIP needs to be removed from the peptide-binding groove by H-2M molecules.
We investigated the functional role of exogenously added CLIP in the modulation of the immune response and its localization in the cell. We have reported earlier that saturation of the endosomal compartment with exogenous CLIP results in reduced class II MHC expression and down-regulation of T cell responses (15) . It has been reported by several workers during the past few years that CLIP binds to class II MHC within the antigen-binding groove (25) (26) (27) (28) . However, there are no reports concerning the functional role of exogenous CLIP in the modulation of the immune response.
Experiments were done to determine if exogenously added CLIP is internalized to affect the immune responses. Our data shows for the first time that exogenously added CLIP is internalized and it co-localizes in MHC class II-containing compartments. It is not clear from our studies where in the endocytic pathway FITC-CLIP is localized, but our data show that it is internalized in a time-dependent fashion and is localized in well-defined subcellular vesicles as opposed to diffuse patches on the cell surface. It has been reported recently that endogenous CLIP localizes with HLA-DR in multimembranous compartments that are positioned late in the endocytic pathway and are the most likely site where CLIP is exchanged for peptide (29) . It is possible that exogenous CLIP also localizes in compartments late in the endocytic pathway but further experiments are needed to confirm this. Although our confocal data showed that FITC-CLIP binds to the cell surface, there was no appreciable colocalization of CLIP with MHC class II on the cell surface. Using a human B cell line, it has been shown that a large population of MHC class II-Ii complexes reaches endosomes by rapid internalization from the cell surface (30) . It is possible that the lack of co-localization on the cell surface may be due to the internalization of the MHC class II-CLIP complexes. The down-regulation of class II MHC expression observed by addition of exogenous CLIP may also be due to the rapid recycling of the MHC-CLIP complexes from the cell surfaces by internalization into endosomes.
We further investigated the effect of CLIP on the immune response induced by various peptide antigens. Three peptides with different affinities for class II MHC were used. We have reported earlier that the peptide K3 with low affinity for class II MHC induces a T h 2-type response while K1A2 with high affinity for class II MHC induces a T h 1-type response. The peptide K4 with intermediate affinity induces both a T h 1-and T h 2-type response (8) . Immunization of mice with K3, K4 and K1A2 along with CLIP significantly down-regulated the proliferative response towards each of the peptides. Immunization with a control peptide OVA(323-339) in place of CLIP also inhibited the response but the inhibitory effect of CLIP was more pronounced. These results suggest that both CLIP and OVA peptides compete with the antigens for binding to class II MHC molecules. This was confirmed by the fact that T cells from OVA plus K3-, K4-or K1A2-immunized mice proliferated in response to OVA peptide also (data not shown).
Immunization of mice with peptides along with CLIP altered the cytokine profile induced by these peptides. An increase in IL-4 secretion was detected in response to all three peptides while IFN-γ production was down-regulated, suggesting a shift towards a T h 2-type response. This was confirmed by the antibody response to these peptides, IgG1 corresponds to T h 2 and IgG2a corresponds to a T h 1-type response (13) . Immunization with K3 plus CLIP up-regulated the IgG1 isotype of antibodies suggesting a stronger T h 2 response. Immunization with K4 plus CLIP down-regulated the IgG2a response while maintaining the IgG1 response suggesting downregulation of T h 1 responses. On the other hand, immunization with K1A2 plus CLIP resulted in a significant increase in IgG1 response and down-regulation of IgG2a, again suggesting a shift from a T h 1-to T h 2-type response. Immunization with peptides plus OVA(323-339) resulted in up-regulation of IFN-γ secretion by K4-and K1A2-primed cells. There was a decrease in IL-4 secretion by K3-primed cells when mice were immunized with K3 plus OVA(323-339) but increase in IFN-γ secretion was not significant. Although both the peptides seem to down-regulate the immune responses, the mechanism of their action could be different. As discussed earlier, exogenously added CLIP down-regulates the expression of class II MHC on the cell surface by rapid internalization of MHC-CLIP complexes (30) . It is possible that after internalization into endosomal compartments CLIP dissociates from the MHC for loading of the peptides. However, saturation of the peptide-loading compartment with exogenous CLIP may inhibit the binding of peptides by competing with the antigen for binding to class II MHC thus resulting in the decreased antigen presentation. The low ligand density on the surface of APC favors the generation of T h 2-type cells. It has been previously demonstrated that ligand density, along with the type of APC and particular epitope presented, is an important factor in determining whether a T h 1-or T h 2-like response is generated (8, 9) . Being an antigenic peptide, OVA(323-339) up-regulates the expression of MHC on the cell surface. Therefore, the down-regulation in proliferative response observed after immunization with K3, K4 or K1A2 peptide in the presence of OVA(323-339) could be due to the competition between these peptides for binding to MHC and subsequent presentation to T cells. The high ligand density on the surface of APC results in the generation of a T h 1-type response (8, 9) . Indeed, OVA(323-339) peptide induces a T h 1-type response when mice are immunized with this peptide alone (data not shown). Generation of T h 1 response by OVA(323-339) peptide may explain the upregulation of IFN-γ secretion after immunization with peptides in the presence of OVA(323-339) peptide. There was a decrease in IL-4 secretion by K3-primed cells after immunization with K3 plus OVA(323-339) peptide but there was no effect on IL-4 secretion by K4-primed cells. One possible explanation for this could be that immunization with OVA(323-339) up-regulates the class II MHC expression leading to increased presentation of K3 resulting in a shift toward a T h 1-type response. We have shown earlier that increasing the immunization dose of K3 compensates for its low affinity and shifts the response towards T h 1 (8) . Another possibility is that due to the lower affinity of K3 it does not compete with OVA(323-339) peptide for binding to MHC as efficiently as K4, resulting in a lower K3-specific response leading to decreased IL-4 secretion. Although there is a down-regulation of IL-4 secretion by K3-primed cells, a very small amount of IFN-γ was detected in these cell cultures suggesting no significant shift in the response towards T h 1. Thus, CLIP down-regulates the immune response and shifts the response toward T h 2 type but OVA(323-339) peptide down-regulates the immune response without altering the T h 1/T h 2 balance.
Protein antigens require processing before presentation to T cells. We investigated the effect of CLIP on the presentation of OVA protein. It was observed that CLIP down-regulated the proliferative response of T cells to OVA. A change in the cytokine profile was also observed. There was an increase in the levels of IL-4 secretion and decrease in IFN-γ production. However, the control immunogenic peptide K1A2 did not have any effect on the response to OVA protein. There are a few possible explanations for the effect of CLIP on immune responses to protein and peptide antigens. First, exogenously added CLIP is internalized and competes with peptide antigens or peptide fragments generated after the processing of proteins for binding to MHC in the peptide-loading compartment. Second, the CLIP-MHC complexes on the cell surface may be structurally different from the MHC class II molecules occupied by other peptides and, therefore, may not present antigen efficiently resulting in reduced response. It has been reported recently that H-2M mutant mice express normal levels of MHC class II but these are structurally distinct from the compact SDS-resistant complexes expressed by wild-type cells and are mostly bound by CLIP (31,32). The APC from the H-2M mutant mice are not efficient in presenting protein or peptide antigens (33) . This may be the case when the peptide-loading compartment is saturated with exogenously added CLIP in our studies resulting in the downregulation of the immune response.
The precise mechanism of exogenous CLIP-mediated down-regulation of MHC expression and subsequent modulation of T cell responses needs to be further elucidated. We postulate that this could involve classical and novel endocytic compartments in the APC. In mouse cells class II vesicles (CIIV) represent a novel endocytic compartment involved in antigen processing and class II peptide loading. In human cells, the MHC class II-enriched compartment (MIIC) represents a lysosome-like endocytic compartment that appears to be involved in this process. Recently, a subcellular compartment morphologically and immunologically similar to human MIIC has been identified in murine B cells (34) . These MIIC-like vesicles represent a population of class II ϩ late endosomes, are distinct from CIIV and appear to be the major repository of DM molecules in these cells. The relationship between CIIV, MIIC and classical endosomes and lysosomes remains to be determined. We postulate that one or more of these compartments are involved in internalization of CLIP and loading of the peptides.
CLIP is able to down-regulate the proliferative response to various antigens without eliminating it. CLIP is also able to alter the nature of the T h subset populations and as a result change the way in which the immune system responds to antigens. The T h 2 subset is important for the generation of humoral immune responses, whereas the T h 1 subset plays a critical role in generating delayed-type hypersensitivity immune responses (11) . The T h 1 subsets are often associated with autoimmune conditions and play an important role in causing inflammatory disorders. Although immunogenic peptides can affect the response to an antigen by competing for presentation and mounting an immune response, CLIP being non-immunogenic can be used to modulate the response to any antigen without concern for an unnecessary response. Moreover, CLIP can modulate the response of protein antigens very effectively while immunogenic peptide used in our study did not have any effect. Therefore, CLIP may be an effective tool to modulate responses to both protein and peptide antigens, and shift them from a pathogenic disease causing a T h 1 immune response towards a T h 2 response that is often associated with protection in a number of autoimmune diseases involving T h 1 cells. 
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